Stock News

A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed

FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia

Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Pfizer Gets FDA Approval for Bleeding Disorder Treatment

Pfizer Receives FDA Approval for Bleeding Disorder Treatment

Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics

AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates

Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks

UPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorder

Pfizer hemophilia gene therapy arrives in US to uncertain future

U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B

Should You Buy Moderna Before May 12?

Wall Street plunges after US inflation shock

Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines

Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma

UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

UPDATE 1-Ad group WPP reports 1.6% drop in first-quarter organic growth

Pfizer Declares Second-Quarter 2024 Dividend

As seen on...